Home › Barrett Esophagus › NCT02634645
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium
Who can join
Ages 18 to 100 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer Exclusion Criteria: * Patients with squamous cell carcinoma
About the study
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
What is being tested
- Endoscopic eradication therapies (EET) (procedure)
- Esophagectomy (procedure)
- Chemotherapy (drug)
- Radiation (radiation)
Sponsor: University of Colorado, Denver · Participants: 5,000 · Started: 2015-01
Contact the study team
- Sachin Wani, MD · Phone: 720-848-2786
- Violette C Simon, MS · Phone: 303-724-6670
Official record on ClinicalTrials.gov — NCT02634645
Locations in the U.S.
| California | UCLA Medical Center, Los Angeles |
| Florida | Moffitt Cancer Center, Tampa |
| Illinois | Northwestern Memorial Hospital, Chicago |
| Missouri | Washington University, St Louis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.